综述 |
|
|
|
|
长链非编码RNA相关表观遗传修饰在癌症中的进展* |
杨万斌1,徐燕1,卓士铉1,王心怡1,李雅静1,郭一凡2,张正光1,郭园园1,**() |
1 南京中医药大学医学院·整合医学学院 南京 210023 2 南京中医药大学药学院 南京 210023 |
|
Progress of Long Non-coding RNAs Related Epigenetic Modifications in Cancer |
YANG Wan-bin1,XU Yan1,ZHUO Shi-xuan1,WANG Xin-yi1,LI Ya-jing1,GUO Yi-fan2,ZHANG Zheng-guang1,GUO Yuan-yuan1,**() |
1 School of Medicine & Holistic Integrative Medicine of Nanjing University of Chinese Medicine, Nanjing 210023, China 2 School of Pharmacy Nanjing University of Chinese Medicine, Nanjing 210023, China |
引用本文:
杨万斌,徐燕,卓士铉,王心怡,李雅静,郭一凡,张正光,郭园园. 长链非编码RNA相关表观遗传修饰在癌症中的进展*[J]. 中国生物工程杂志, 2021, 41(8): 59-66.
YANG Wan-bin,XU Yan,ZHUO Shi-xuan,WANG Xin-yi,LI Ya-jing,GUO Yi-fan,ZHANG Zheng-guang,GUO Yuan-yuan. Progress of Long Non-coding RNAs Related Epigenetic Modifications in Cancer. China Biotechnology, 2021, 41(8): 59-66.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2104019
或
https://manu60.magtech.com.cn/biotech/CN/Y2021/V41/I8/59
|
[1] |
Chen S J, Li F Y, Xu D, et al. The function of RAS mutation in cancer and advances in its drug research. Current Pharmaceutical Design, 2019, 25(10):1105-1114.
doi: 10.2174/1381612825666190506122228
|
[2] |
范源, 罗嘉, 甘麦邻, 等. 长链非编码RNA TERRA的研究进展. 中国生物工程杂志, 2018, 38(10):64-73.
|
|
Fan Y, Luo J, Gan M L, et al. The research advance of long non-coding RNA TERRA. China Biotechnology, 2018, 38(10):64-73.
|
[3] |
Ruiz-Orera J, Messeguer X, Subirana J A, et al. Long non-coding RNAs as a source of new peptides. eLife, 2014, 3:e03523. DOI: 10.7554/eLife.03523.
doi: 10.7554/eLife.03523
|
[4] |
Huang J Z, Chen M, Chen D, et al. A peptide encoded by a putative lncRNA HOXB-AS3 suppresses colon cancer growth. Molecular Cell, 2017, 68(1):171-184.e6.
doi: 10.1016/j.molcel.2017.09.015
|
[5] |
万群, 刘梦瑶, 夏菁, 等. 长链非编码RNA SNHG3对人乳腺癌细胞MCF-7增殖、迁移与侵袭的影响. 中国生物工程杂志, 2019, 39(1):13-20.
|
|
Wan Q, Liu M Y, Xia J, et al. The effects of LncRNA SNHG3 on the proliferation, migration and invasion of human breast cancer MCF-7 cells. China Biotechnology, 2019, 39(1):13-20.
|
[6] |
Kelly A D, Issa J P J. The promise of epigenetic therapy: reprogramming the cancer epigenome. Current Opinion in Genetics & Development, 2017, 42:68-77.
|
[7] |
堵晶晶, 谭镇东, 刘辰东, 等. 长链非编码RNA的研究现状. 中国生物工程杂志, 2016, 36(9):59-74.
|
|
Du J J, Tan Z D, Liu C D, et al. Research progress of long non-coding RNAs. China Biotechnology, 2016, 36(9):59-74.
|
[8] |
Moore L D, Le T, Fan G P. DNA methylation and its basic function. Neuropsychopharmacology, 2013, 38(1):23-38.
doi: 10.1038/npp.2012.112
pmid: 22781841
|
[9] |
Edwards J R, Yarychkivska O, Boulard M, et al. DNA methylation and DNA methyltransferases. Epigenetics & Chromatin, 2017, 10(1):1-10.
|
[10] |
Robert M F, Morin S, Beaulieu N, et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nature Genetics, 2003, 33(1):61-65.
doi: 10.1038/ng1068
|
[11] |
Song Y, Zhou T, Zong Y Q, et al. Arsenic inhibited cholesterol efflux of THP-1 macrophages via ROS-mediated ABCA1 hypermethylation. Toxicology, 2019, 424:152225.
doi: 10.1016/j.tox.2019.05.012
|
[12] |
Xing X Q, Li B, Xu S L, et al. 5-Aza-2'-deoxycytidine, a DNA methylation inhibitor, attenuates hypoxic pulmonary hypertension via demethylation of the PTEN promoter. European Journal of Pharmacology, 2019, 855:227-234.
doi: S0014-2999(19)30325-5
pmid: 31085236
|
[13] |
Liu D L, Wu K, Yang Y, et al. Long noncoding RNA ADAMTS9-AS2 suppresses the progression of esophageal cancer by mediating CDH3 promoter methylation. Molecular Carcinogenesis, 2020, 59(1):32-44.
doi: 10.1002/mc.v59.1
|
[14] |
Kang X W, Kong F W, Huang K, et al. LncRNA MIR210HG promotes proliferation and invasion of non-small cell lung cancer by upregulating methylation of CACNA2D2 promoter via binding to DNMT1. OncoTargets and Therapy, 2019, 12:3779-3790.
doi: 10.2147/OTT
|
[15] |
Ruscio A D, Ebralidze A K, Benoukraf T, et al. DNMT1-interacting RNAs block gene-specific DNA methylation. Nature, 2013, 503(7476):371-376.
doi: 10.1038/nature12598
|
[16] |
Qi D F, Li J H, Que B, et al. Long non-coding RNA DBCCR1-003 regulate the expression of DBCCR1 via DNMT1 in bladder cancer. Cancer Cell International, 2016, 16:81.
doi: 10.1186/s12935-016-0356-8
|
[17] |
Yin Y M, Morgunova E, Jolma A, et al. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science, 2017, 356(6337):eaaj2239. DOI: 10.1126/science.aaj2239.
doi: 10.1126/science.aaj2239
|
[18] |
Arab K, Karaulanov E, Musheev M, et al. GADD45A binds R-loops and recruits TET1 to CpG island promoters. Nature Genetics, 2019, 51(2):217-223.
doi: 10.1038/s41588-018-0306-6
|
[19] |
Zhou L Y, Ren M, Zeng T T, et al. TET2-interacting long noncoding RNA promotes active DNA demethylation of the MMP-9 promoter in diabetic wound healing. Cell Death & Disease, 2019, 10:813.
|
[20] |
Chen Y, Lin Y, Shu Y, et al. Interaction between N(6)-methyladenosine (m(6)A) modification and noncoding RNAs in cancer. Mol Cancer, 2020, 19(1):94.
doi: 10.1186/s12943-020-01207-4
pmid: 32443966
|
[21] |
Huang H L, Weng H Y, Chen J J. m6A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell, 2020, 37(3):270-288.
doi: 10.1016/j.ccell.2020.02.004
|
[22] |
Patil D P, Pickering B F, Jaffrey S R. Reading m6A in the transcriptome: m6A-binding proteins. Trends in Cell Biology, 2018, 28(2):113-127.
doi: 10.1016/j.tcb.2017.10.001
|
[23] |
Zuo L, Su H, Zhang Q, et al. Comprehensive analysis of lncRNAs N6-methyladenosine modification in colorectal cancer. Aging, 2021, 13(3):4182-4198.
doi: 10.18632/aging.v13i3
|
[24] |
Zuo X L, Chen Z Q, Gao W, et al. M6A-mediated upregulation of LINC00958 increases lipogenesis and Acts as a nanotherapeutic target in hepatocellular carcinoma. Journal of Hematology & Oncology, 2020, 13(1):5.
|
[25] |
Zheng Z Q, Li Z X, Zhou G Q, et al. Long noncoding RNA FAM225A promotes nasopharyngeal carcinoma tumorigenesis and metastasis by acting as CeRNA to sponge miR-590-3p/miR-1275 and upregulate ITGB3. Cancer Research, 2019, 79(18):4612-4626.
doi: 10.1158/0008-5472.CAN-19-0799
|
[26] |
Yang D D, Qiao J, Wang G Y, et al. N6-methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential. Nucleic Acids Research, 2018, 46(8):3906-3920.
doi: 10.1093/nar/gky130
|
[27] |
Zhang S C, Zhao B S, Zhou A D, et al. m6A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program. Cancer Cell, 2017, 31(4):591-606.e6.
doi: 10.1016/j.ccell.2017.02.013
|
[28] |
Lan T, Li H, Zhang D L, et al. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Molecular Cancer, 2019, 18(1):186.
doi: 10.1186/s12943-019-1106-z
|
[29] |
Wang Y, Lu J H, Wu Q N, et al. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Molecular Cancer, 2019, 18(1):174.
doi: 10.1186/s12943-019-1105-0
pmid: 31791342
|
[30] |
Hsu J M, Li C W, Lai Y J, et al. Posttranslational modifications of PD-L1 and their applications in cancer therapy. Cancer Research, 2018, 78(22):6349-6353.
doi: 10.1158/0008-5472.CAN-18-1892
|
[31] |
Poulard C, Corbo L, Le Romancer M. Protein arginine methylation/demethylation and cancer. Oncotarget, 2016, 7(41):67532-67550.
doi: 10.18632/oncotarget.v7i41
|
[32] |
Tsai M C, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science, 2010, 329(5992):689-693.
doi: 10.1126/science.1192002
|
[33] |
Zhou H L, Luo G B, Wise J A, et al. Regulation of alternative splicing by local histone modifications: potential roles for RNA-guided mechanisms. Nucleic Acids Research, 2014, 42(2):701-713.
doi: 10.1093/nar/gkt875
|
[34] |
Jiang B, Yang B, Wang Q, et al. lncRNA PVT1 promotes hepatitis B virus-positive liver cancer progression by disturbing histone methylation on the c-Myc promoter. Oncology Reports, 2020, 43(2):718-726.
doi: 10.3892/or.2019.7444
pmid: 31894346
|
[35] |
Yu Y, Zhang M J, Liu J, et al. Long non-coding RNA PVT1 promotes cell proliferation and migration by silencing ANGPTL4 expression in cholangiocarcinoma Molecular Therapy - Nucleic Acids, 2018, 13:503-513.
doi: 10.1016/j.omtn.2018.10.001
|
[36] |
Song Y, Wang R, Li L W, et al. Long non-coding RNA HOTAIR mediates the switching of histone H3 lysine 27 acetylation to methylation to promote epithelial-to-mesenchymal transition in gastric cancer. International Journal of Oncology, 2019, 54(1):77-86.
doi: 10.3892/ijo.2018.4625
pmid: 30431069
|
[37] |
Yu S X, Yang D L, Ye Y Y, et al. Long noncoding RNA actin filament-associated protein 1 antisense RNA 1 promotes malignant phenotype through binding with lysine-specific demethylase 1 and repressing HMG box-containing protein 1 in non-small-cell lung cancer. Cancer Science, 2019, 110(7):2211-2225.
doi: 10.1111/cas.2019.110.issue-7
|
[38] |
Chen Z Y, Chen X, Lu B B, et al. Up-regulated LINC01234 promotes non-small-cell lung cancer cell metastasis by activating VAV3 and repressing BTG2 expression. Journal of Hematology & Oncology, 2020, 13(1):1-14.
|
[39] |
Guo P P, Chen W Q, Li H Y, et al. The histone acetylation modifications of breast cancer and their therapeutic implications. Pathology & Oncology Research, 2018, 24(4):807-813.
|
[40] |
Pan Z W, Mao W M, Bao Y J, et al. The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer. Cancer Medicine, 2016, 5(9):2442-2447.
doi: 10.1002/cam4.2016.5.issue-9
|
[41] |
Liang Y, Chen X D, Wu Y Y, et al. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein. Cell Death and Differentiation, 2018, 25(11):1980-1995.
doi: 10.1038/s41418-018-0084-9
pmid: 29511340
|
[42] |
Ma H L, Chang H Y, Yang W Y, et al. A novel IFNα-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma. Molecular Cancer, 2020, 19(1):1-16.
doi: 10.1186/s12943-019-1085-0
|
[43] |
Wang Y, Chen W Y, Lian J Y, et al. The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α. Cell Death & Differentiation, 2020, 27(2):695-710.
|
[44] |
Ding G Q, Li W, Liu J P, et al. LncRNA GHET1 activated by H3K27 acetylation promotes cell tumorigenesis through regulating ATF1 in hepatocellular carcinoma. Biomedicine & Pharmacotherapy, 2017, 94:326-331.
doi: 10.1016/j.biopha.2017.07.046
|
[45] |
Yi T B, Zhou X Q, Sang K, et al. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-κB pathway. Artificial Cells, Nanomedicine, and Biotechnology, 2019, 47(1):3765-3773.
doi: 10.1080/21691401.2019.1664559
|
[46] |
Ye P, Lv X, Aizemaiti R, et al. H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis. Cell Proliferation, 2020, 53(5):e12797.
|
[47] |
Liu D S, Zhang H, Cong J C, et al. H3K27 acetylation-induced lncRNA EIF3J-AS1 improved proliferation and impeded apoptosis of colorectal cancer through miR-3163/YAP1 axis. Journal of Cellular Biochemistry, 2020, 121(2):1923-1933.
doi: 10.1002/jcb.v121.2
|
[48] |
Chen F B, Qi S C, Zhang X, et al. lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β-catenin pathway in oral squamous cell carcinoma. International Journal of Oncology, 2019, 54(4):1183-1194.
|
[49] |
Tang J M, Zhong G S, Zhang H B, et al. LncRNA DANCR upregulates PI3K/AKT signaling through activating serine phosphorylation of RXRA. Cell Death & Disease, 2018, 9:1167.
|
[50] |
Yang Y, Zhang J P, Chen X, et al. LncRNA FTX sponges miR-215 and inhibits phosphorylation of vimentin for promoting colorectal cancer progression. Gene Therapy, 2018, 25(5):321-330.
doi: 10.1038/s41434-018-0026-7
pmid: 29925853
|
[51] |
Faktor J, Pjechová M, Hernychová L, et al. Protein ubiquitination research in oncology. Klinicka Onkologie, 2019, 32(Suppl 3):56-64. DOI: 10.14735/amko20193s56.
doi: 10.14735/amko20193s56
|
[52] |
Zhao B, Tsai Y C, Jin B, et al. Protein engineering in the ubiquitin system: tools for discovery and beyond. Pharmacological Reviews, 2020, 72(2):380-413.
doi: 10.1124/pr.118.015651
pmid: 32107274
|
[53] |
Cao S Z, Wang Y Z, Li J Q, et al. Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by suppressing miR-155 expression and activating FBXW7 function. American Journal of Cancer Research, 2016, 6(11):2561-2574.
|
[54] |
Wu G Z, Cai J, Han Y, et al. LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation, 2014, 130(17):1452-1465.
doi: 10.1161/CIRCULATIONAHA.114.011675
|
[55] |
Zhang A, Zhao J C, Kim J, et al. LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer. Cell Reports, 2015, 13(1):209-221.
doi: S2211-1247(15)00982-1
pmid: 26411689
|
[56] |
Wani W Y, Chatham J C, Darley-Usmar V, et al. O-GlcNAcylation and neurodegeneration. Brain Research Bulletin, 2017, 133:80-87.
doi: 10.1016/j.brainresbull.2016.08.002
|
[57] |
Girotti M R, Salatino M, Dalotto-Moreno T, et al. Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression. Journal of Experimental Medicine, 2020, 217(2). DOI: 10.1084/jem.20182041.
doi: 10.1084/jem.20182041
|
[58] |
Pan S M, Liu Y Q, Liu Q Q, et al. HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2019, 1866(5):750-760.
doi: 10.1016/j.bbamcr.2019.02.004
|
[59] |
Hu J L, Shan Y J, Ma J, et al. LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating α-2, 3 sialylation via PI3K/Akt signaling. International Journal of Cancer, 2019, 145(2):450-460.
doi: 10.1002/ijc.v145.2
|
[60] |
Zhao Q, Zheng K, Ma C M, et al. PTPS facilitates compartmentalized LTBP1 S-nitrosylation and promotes tumor growth under hypoxia. Molecular Cell, 2020, 77(1):95-107.e5.
doi: S1097-2765(19)30723-3
pmid: 31628042
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|